Monday, October 26, 2026 · Daily editionET --:--:--

Status not kept up to date

Robotic-assisted Percutaneous Transhepatic Puncture

NCT06195917 · Zhongda Hospital · Updated 19 April 2024

What is being tested
Robotic-assisted Interventional Percutaneous transhepatic puncture
For
Liver Diseases
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years and older. About 20 people. The full rules are on the registry page.
Where
China
When
Starts or started 19 Sept 2023, ends 1 May 2024. Registered 8 Jan 2024.
Results
None posted yet.

In the researchers' words

This is a first-in-man study to investigate the feasibility and safety profile of the newly developed robotic system for percutaneous transhepatic interventional procedures, including biopsy and ablation. Participants who were clinically assessed in need of a liver lesion puncture were included in this study.
ClinicalTrials.gov, NCT06195917

Sites

  • Centre of Interventional Radiology and Vascular Surgery, Department of Radiology, Zhongda Hospital, Southeast UniversityNanjing, Jiangsu, China